We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$334B
AUM Growth
+$44B
Cap. Flow
+$10.5B
Cap. Flow %
3.13%
Top 10 Hldgs %
13.87%
Holding
10,649
New
1,223
Increased
4,779
Reduced
2,819
Closed
1,395

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 7.1%
3 Healthcare 6%
4 Consumer Discretionary 5.02%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMJ
8226
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.62K ﹤0.01%
64
-172
-73% -$4.32K
OCAX
8227
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$1.62K ﹤0.01%
+150
New +$1.61K
VGAS icon
8228
Verde Clean Fuels
VGAS
$22.5M
$1.61K ﹤0.01%
684
-1,674
-71% -$5.15K
EALT icon
8229
Innovator US Equity 5 to 15 Buffer ETF Quarterly
EALT
$166M
$1.61K ﹤0.01%
+59
New +$1.55K
CBIO
8230
Crescent Biopharma
CBIO
$537M
$1.61K ﹤0.01%
+7
New +$1.09K
BCEL
8231
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.61K ﹤0.01%
12,210
+5,779
+90% +$1.36K
NRGD
8232
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
$1.61K ﹤0.01%
7
-3,210
-100% -$750K
BDRX
8233
Biodexa Pharmaceuticals
BDRX
$1.19M
0
SNOA icon
8234
Sonoma Pharmaceuticals
SNOA
$5.26M
$1.61K ﹤0.01%
+447
New +$2.85K
SBEV icon
8235
Splash Beverage Group
SBEV
$2.33M
$1.6K ﹤0.01%
+18
New +$1.71K
XVV icon
8236
iShares ESG Screened S&P 500 ETF
XVV
$648M
$1.6K ﹤0.01%
44
-811
-95% -$27.6K
BETS
8237
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
$1.6K ﹤0.01%
+145
New +$24.1K
QRMI icon
8238
Global X NASDAQ 100 Risk Managed Income ETF
QRMI
$15.5M
$1.59K ﹤0.01%
93
+73
+365% +$1.24K
MOBXW icon
8239
Mobix Labs Warrants
MOBXW
$1.58K ﹤0.01%
22,620
-18,011
-44% -$537
SUNE
8240
SUNation Energy
SUNE
$8.95M
0
VEV
8241
DELISTED
Vicinity Motor Corp. Common Stock
VEV
$1.58K ﹤0.01%
1,928
+1,787
+1,267% +$1.51K
PPBT
8242
Purple Biotech
PPBT
$1.31M
$1.56K ﹤0.01%
10
+1
+11% +$221
TPCS icon
8243
TechPrecision Corp
TPCS
$47.3M
$1.56K ﹤0.01%
301
-3,503
-92% -$22.9K
ETAO
8244
DELISTED
Etao International Co., Ltd. Ordinary Shares
ETAO
$1.56K ﹤0.01%
+173
New +$924
AWH
8245
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.55K ﹤0.01%
381
YI
8246
111 Inc
YI
$33.9M
$1.55K ﹤0.01%
+100
New +$2.08K
FTLF icon
8247
FitLife Brands
FTLF
$93.1M
$1.55K ﹤0.01%
162
-10
-6% -$102
KOLD icon
8248
ProShares UltraShort Bloomberg Natural Gas
KOLD
$96.3M
$1.54K ﹤0.01%
32
-1,006
-97% -$35.2K
CELUW
8249
DELISTED
Celularity Inc
CELUW
$1.54K ﹤0.01%
+38,556
New +$663
RDZN icon
8250
Roadzen
RDZN
$97.2M
$1.54K ﹤0.01%
303
+193
+175% +$800

Similar funds

UBS Group's Q4 2023 Portfolio in Review

As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.

  • UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
  • UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
  • UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
  • UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
  • UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
  • UBS Group opened 1,223 new positions and closed 1,395 in Q4 2023.
  • UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.